Trusted TV doctors “deepfaked” to promote health scams on social media

The BMJ investigates the rise of videos claiming to be UK’s popular media medics Some of the UK’s most recognisable TV doctors are increasingly being “deepfaked” in videos to sell scam products across social media, finds The BMJ today. Trusted names including Hilary Jones, Michael Mosley and Rangan Chatterjee are being used ...

2024-07-18T10:59:10+00:0018 July 2024|Press release, The BMJ|

No increased risk of birth defects after covid-19 infection or vaccination in early pregnancy

Findings support safety of vaccination for pregnant women Neither covid-19 infection nor vaccination during the first trimester of pregnancy is associated with increased risk of major birth defects, finds a study from Scandinavia published by The BMJ today. It’s well known that women who experience covid-19 infection during pregnancy are at increased ...

2024-07-18T10:57:18+00:0018 July 2024|Press release, The BMJ|

NHS’s relentless focus on finance and productivity is failing patient safety

Patients’ concerns too often go ignored, says England’s first patient safety commissioner “The NHS’s relentless focus on finance and productivity is failing patient safety,” argues patient safety commissioner Henrietta Hughes in an interview for The BMJ today. “The patient’s anecdote is the canary in the coal mine,” she says. It’s the thing ...

2024-08-01T08:51:20+00:009 July 2024|Press release, The BMJ|

Intensive voice treatment more effective than NHS speech therapy for Parkinson’s disease

Results highlight need to optimise speech therapy resources, say researchers An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published ...

2024-08-01T08:49:31+00:009 July 2024|Press release, The BMJ|

FDA staff leaving for industry jobs given “behind the scenes” lobbying advice

Practice highlights “critical loophole” in the revolving door between the FDA and industry The US Food and Drug Administration (FDA) tells staff leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency, reveals an investigation by The BMJ today. Internal emails, obtained under a ...

2024-07-02T15:12:11+00:002 July 2024|Press release, The BMJ|
Go to Top